Set up 24x7 RAT booths at different locations: Centre to states, UTs

India has a network of 3,117 molecular testing laboratories, which includes 2014 RT-PCR, 941 TrueNat, 132 CBNAAT and 30 other testing platforms

A health worker takes a swab sample at a pop-up Covid-19 testing station in the Sanlitun area of Beijing, China, on Thursday, Aug. 5, 2021. China imposed new travel and movement restrictions amid a delta-driven outbreak that's grown to over 500 sympt
Representational image
Press Trust of India New Delhi
3 min read Last Updated : Jan 01 2022 | 1:08 AM IST

Amid the new surge in Covid cases, the Centre has asked all states and union territories to set up round-the-clock Rapid Antigen Test booths at different locations, engage medical and paramedical staff, and encourage the use of home test kits for symptomatic individuals.

In a letter to all chief secretaries, Union Health Secretary Rajesh Bhushan and ICMR Director General Balram Bhargava said any individual having fever with/without cough, headache, sore throat, breathlessness, body ache, the recent loss of taste or smell, fatigue, and diarrhoea should be considered as a suspect case of COVID-19 unless proven otherwise.

"All such individuals must be tested. While awaiting the test results, they should be advised to immediately isolate themselves and follow the home isolation guidelines of Ministry of Health & Family Welfare," the letter said.

It said that as of now, India has a network of 3,117 molecular testing laboratories, which includes 2014 RT-PCR, 941 TrueNat, 132 CBNAAT and 30 other testing platforms.

The estimated national daily molecular testing capacity is more than 20 lakh per day, the letter to the chief secretaries said. "You are advised to upscale testing for Covid-19 in your State/UT by fully utilizing the existing molecular testing capacity."

"In addition, you may also expedite procurement of necessary testing equipment and establish BSL-2 laboratory infrastructure from the funds sanctioned to your State/UT by the Ministry of Health and Family Welfare, under the Emergency COVID-19 Response Plan (ECRP)," it said

The letter said that RTPCR-based testing leads to delays in confirming diagnosis due to its turnaround time of about 5-8 hours. "Therefore, you are encouraged to increase testing by widespread use of rapid antigen tests (RATS) in such specific situations where RTPCR testing poses challenges," the two senior health officials said in the letter.

In such specific situations, it is recommended to increase rapid antigen testing for COVID-19 through multiple RAT booths in identified geographies and operationalised on a 24x7 basis to offer widespread testing and easier access to all citizens, they said.

"RATS may be allowed at government and private health care facilities including all hospitals, dispensaries, nursing homes, clinics, district hospitals, primary health centers etc," they said.

In addition to healthcare facilities, states and union territories are also encouraged to engage appropriate medical and paramedical staff and to set up and operationalse RAT booths at convenient locations, they said.

The use of self-tests/home tests may be encouraged for symptomatic individuals, they said, adding seven such home testing kits have been approved so far and two of them are also available on GeM.

Most of the test kits/products approved by Indian Council of Medical Research are now available on the GeM portal and can be easily procured from GeM, the letter said.

"Appropriate public-private partnership models may also be explored to establish innovative and convenient testing centers to augment testing in an expeditious way. RATS must be conducted in accordance with RAT algorithm defined by ICMR," the letter said.

"You may appropriately refine the State procurement procedures for emergency procurement from market to expedite the process," they said.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Coronavirusindian governmentCoronavirus Tests

First Published: Jan 01 2022 | 1:08 AM IST

Next Story